CSIMarket
 
Abiomed Inc   (NASDAQ: ABMD)
 

Abiomed Inc's Customers Performance

ABMD



 
ABMD's Source of Revenues During the corresponding time, Abiomed Inc recorded a revenue increase by 7.16 % year on year, sequentially revenue fell by -4.05 %. While revenue at the Abiomed Inc 's corporate clients

• List of ABMD Customers




for the same period Abiomed Inc recorded revenue increase by 7.16 % year on year, sequentially revenue fell by -4.05 %.

• List of ABMD Customers

Abiomed Inc's Business Units






Abiomed Inc's Comment on Sales, Marketing and Customers
















ABMD's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Abiomed Inc 17,416.81 1,074.10 266.76 1,000
Abbvie Inc 522,793.16 66,014.00 10,346.00 57,000
Ac Immune Sa 214.60 4.31 -85.03 55
Addex Therapeutics Ltd 0.00 0.03 -6.73 17
Alkermes Plc 8,294.68 1,753.60 -0.35 2,050
Arcturus Therapeutics Holdings Inc 237.62 29.37 -93.28 111
SUBTOTAL 3,638,776.49 2,912,408.09 82,906.06 5,730,718
11 more clients available

Sign in to see all corporate customers for Abiomed Inc .

Sources: Abiomed Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Abiomed Inc’s corporate clients.
For your research, we’ve provided 9 tables on Abiomed Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.